Cargando…

Performance evaluation of the Elecsys PIVKA‐II and Elecsys AFP assays for hepatocellular carcinoma diagnosis

BACKGROUND AND AIMS: Prothrombin induced by vitamin K absence‐II (PIVKA‐II) is a serum biomarker linked to hepatocellular carcinoma (HCC), showing superiority to alpha‐fetoprotein (AFP) for early disease detection. We aimed to assess the clinical and analytical performance of the Elecsys® PIVKA‐II i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chan, Henry L Y, Vogel, Arndt, Berg, Thomas, De Toni, Enrico N, Kudo, Masatoshi, Trojan, Jörg, Eiblmaier, Anja, Klein, Hanns‐Georg, Hegel, Johannes Kolja, Sharma, Ashish, Madin, Kairat, Rolny, Vinzent, Lisy, Marcus‐Rene, Piratvisuth, Teerha
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wiley Publishing Asia Pty Ltd 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9120909/ https://www.ncbi.nlm.nih.gov/pubmed/35601131 http://dx.doi.org/10.1002/jgh3.12720

Ejemplares similares

Development and clinical validation of a novel algorithmic score (GAAD) for detecting HCC in prospective cohort studies
por: Piratvisuth, Teerha, et al.
Publicado: (2023)

Clinical evaluation of Elecsys PIVKA-II for patients with advanced hepatocellular carcinoma
por: Kaneko, Shun, et al.
Publicado: (2022)

Performance evaluation of the Roche Elecsys Anti-SARS-CoV-2 S immunoassay
por: Riester, Elena, et al.
Publicado: (2021)

Analytical performance evaluation of the Elecsys® Cyclosporine and Elecsys® Tacrolimus assays on the cobas e411 analyzer
por: Sasano, Maki, et al.
Publicado: (2017)

Data on the Relationships of Signal-To-Cutoff Ratios of Elecsys HIV Antigen/Antibody and Elecsys Syphilis Assays to Subsequent Confirmatory Testing at an Academic Medical Center
por: Chopra, Saurav, et al.
Publicado: (2021)

Comparison of Specific Ovarian Tumor Markers by Elecsys Analyzer 2010
por: Hasanbegovic, Lejla, et al.
Publicado: (2015)

Multicentre Performance Evaluation of the Elecsys Anti-SARS-CoV-2 Immunoassay as an Aid in Determining Previous Exposure to SARS-CoV-2
por: Riester, Elena, et al.
Publicado: (2021)

Clinical evaluation of the Roche Elecsys® CMV IgG Avidity assay
por: Vauloup-Fellous, C., et al.
Publicado: (2014)

Evaluation of the Elecsys syphilis immunoassay for routine screening of serum samples in China
por: Tao, Chuanmin, et al.
Publicado: (2017)

Elecsys CSF biomarker immunoassays demonstrate concordance with amyloid-PET imaging
por: Doecke, James D., et al.
Publicado: (2020)

Clinical Application Evaluation of Elecsys(®) HIV Duo Assay in Southwest China
por: Yang, Mei, et al.
Publicado: (2022)

Usefulness of AFP, AFP-L3, and PIVKA-II, and their combinations in diagnosing hepatocellular carcinoma
por: Park, Sang Joon, et al.
Publicado: (2017)

Evaluation of Elecsys Syphilis Assay for Routine and Blood Screening and Detection of Early Infection
por: Kremastinou, J., et al.
Publicado: (2016)

Derivation of cutoffs for the Elecsys(®) amyloid β (1–42) assay in Alzheimer's disease
por: Shaw, Leslie M., et al.
Publicado: (2018)

Design and performance characteristics of the Elecsys anti-SARS-CoV-2 S assay
por: Taffertshofer, Karin, et al.
Publicado: (2022)

Multicentre evaluation of the Roche Elecsys® Active B(12) (holotranscobalamin) electro-chemiluminescence immunoassay
por: Heil, Sandra G, et al.
Publicado: (2019)

A method to alleviate false-positive results of the Elecsys HIV combi PT assay
por: Lu, Xiaolan, et al.
Publicado: (2021)

Assessment of the Concordance and Diagnostic Accuracy Between Elecsys and Lumipulse Fully Automated Platforms and Innotest
por: Dakterzada, Farida, et al.
Publicado: (2021)

Sensitivity of the Elecsys Nucleocapsid Assay for the Detection of Preceding SARS-CoV-2 Infections
por: Grunau, Brian, et al.
Publicado: (2022)

Performance evaluation of Elecsys HIV Duo on cobas e 801 using clinical samples in China
por: Zhang, Bowen, et al.
Publicado: (2020)

The diagnostic value of PIVKA‐II, AFP, AFP‐L3, CEA, and their combinations in primary and metastatic hepatocellular carcinoma
por: Qi, Famei, et al.
Publicado: (2019)

Validation of combined AFP, AFP-L3, and PIVKA II for diagnosis and monitoring of hepatocellular carcinoma in Chinese patients
por: Ren, Tianying, et al.
Publicado: (2023)

Multicenter evaluation of the Elecsys Toxo IgG and IgM tests for the diagnosis of infection with Toxoplasma gondii
por: Meylan, Pascal, et al.
Publicado: (2015)

Clinical performance of the Roche Elecsys SARS-CoV-2 antigen fully automated electrochemiluminescence immunoassay
por: Salvagno, Gian Luca, et al.
Publicado: (2022)

Utility of Roche Elecsys anti-SARS-CoV-2 S in ascertaining post-vaccine neutralizing antibodies
por: Aijaz, Javeria, et al.
Publicado: (2023)

Evaluation of Ortho VITROS and Roche Elecsys S and NC Immunoassays for SARS-CoV-2 Serosurveillance Applications
por: Sulaeman, Hasan, et al.
Publicado: (2023)

Elecsys Cerebrospinal Fluid Immunoassays Accurately Detect Alzheimer’s Disease Regardless of Concomitant Small Vessel Disease
por: Ortner, Marion, et al.
Publicado: (2023)

PIVKA-II serves as a potential biomarker that complements AFP for the diagnosis of hepatocellular carcinoma
por: Feng, Honglei, et al.
Publicado: (2021)

The value of PIVKA-Ⅱ versus AFP for the diagnosis and detection of postoperative changes in hepatocellular carcinoma
por: Lee, Qiuyan, et al.
Publicado: (2021)

Clinical value of serum AFP and PIVKA‐II for diagnosis, treatment and prognosis of hepatocellular carcinoma
por: Tian, Shan, et al.
Publicado: (2022)

Evaluation of Sensitivity and Specificity Performance of Elecsys HTLV-I/II Assay in a Multicenter Study in Europe and Japan
por: Laperche, Syria, et al.
Publicado: (2017)

Reduced Relative Sensitivity of the Elecsys SARS-CoV-2 Antigen Assay in Saliva Compared to Nasopharyngeal Swabs
por: Audigé, Annette, et al.
Publicado: (2021)

Comparing CSF amyloid‐beta biomarker ratios for two automated immunoassays, Elecsys and Lumipulse, with amyloid PET status
por: Willemse, Eline A. J., et al.
Publicado: (2021)

Cortisol values during the standard-dose cosyntropin stimulation test: Personal experience with Elecsys cortisol II assay
por: Husni, Hasan, et al.
Publicado: (2022)

An Analysis of Predictive Sample-to-Cutoff Index for HIV Infection Confirmation Using Elecsys® HIV Combi PT Assay
por: Xia, Xiaohong, et al.
Publicado: (2022)

Diagnostic Performance of AFP, AFP-L3, or PIVKA-II for Hepatitis C Virus-Associated Hepatocellular Carcinoma: A Multicenter Analysis
por: Liu, Siyu, et al.
Publicado: (2022)

The Diagnostic Value of Serum PIVKA-II Alone or in Combination with AFP in Chinese Hepatocellular Carcinoma Patients
por: Xu, Fei, et al.
Publicado: (2021)

Utility of combining PIVKA-II and AFP in the surveillance and monitoring of hepatocellular carcinoma in the Asia-Pacific region
por: Kim, Do Young, et al.
Publicado: (2023)

The diagnostic performance of AFP and PIVKA-II models for non-B non-C hepatocellular carcinoma
por: Tran, Vinh Thanh, et al.
Publicado: (2023)

Evaluation of the Elecsys Chagas Assay for Detection of Trypanosoma cruzi-Specific Antibodies in a Multicenter Study in Europe and Latin America
por: Flores-Chavez, Maria Delmans, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_052ii1trs3p19hmiikj97g4li8